First Light Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

First Light Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,560,991	Closed	-$62M	–	32
2026 Q1	$62M	Sell	1,560,991 -717,949	-32%	-$18.4M	5.56%	5
2025 Q4	$57M	Sell	2,278,940 -1,356,876	-37%	-$34.4M	4.36%	5
2025 Q3	$88.2M	Sell	3,635,816 -657,595	-15%	-$11.7M	8.31%	3
2025 Q2	$56.4M	Sell	4,293,411 -580,713	-12%	-$7.36M	7.31%	2
2025 Q1	$70.1M	Sell	4,874,124 -931,060	-16%	-$15.2M	8%	3
2024 Q4	$97.2M	Sell	5,805,184 -134,948	-2%	-$2.24M	9.3%	2
2024 Q3	$95M	Buy	5,940,132 +1,159,572	+24%	+$14.2M	7.9%	1
2024 Q2	$43.2M	Buy	4,780,560 +1,778,515	+59%	+$16.9M	3.78%	9
2024 Q1	$33.9M	Buy	+3,002,045	New	+$28.4M	2.6%	15

First Light Asset Management's CNTA Position: Q2 2026 in Review

First Light Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 1,560,991 shares — an estimated $62M sold.

First Light Asset Management first reported a position in CNTA in Q1 2024 and held it in 9 quarters. The position peaked at $97.2M in Q4 2024. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

First Light Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
First Light Asset Management sold 1,560,991 Centessa Pharmaceuticals shares in Q2 2026, an estimated $62M.
First Light Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2024 and held it in 9 quarters.
First Light Asset Management's Centessa Pharmaceuticals position peaked at $97.2M in Q4 2024.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on First Light Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.